Arvinas (ARVN) Common Equity (2017 - 2026)
Arvinas (ARVN) reported Common Equity of $562.2 million for Q2 2026, down 7.7% from $609.3 million a year earlier but up 45.3% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas posted Common Equity of $433.9 million, down 22.8% from FY2024.
- Common Equity has a five-year compound annual growth rate of -7.5% (FY2020 to FY2025).
- By year, Common Equity came in at $561.7 million in FY2024 (-14.9%), $660 million in FY2023 (+16.8%), $564.9 million in FY2022 (-27.7%) and $781.7 million in FY2021 (+21.7%).
- Five-year quarterly Common Equity spans a low of $386.8 million in Q1 2026 and a high of $817.7 million in Q3 2021.
- Year over year, Common Equity has now declined in each of the last four quarters, with an average decline of 6.6% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 298.6%); the low point was Q1 2026 (a decline of 41.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $386.8 million (Q1 2026), $433.9 million (Q4 2025) and $564.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Arvinas | 490.40 Mn | -2.17 Bn | - | 562.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 562.20 Mn |
| Mar 31, 2026 | 386.80 Mn |
| Dec 31, 2025 | 433.90 Mn |
| Sep 30, 2025 | 564.40 Mn |
| Jun 30, 2025 | 609.30 Mn |
| Mar 31, 2025 | 660.10 Mn |
| Dec 31, 2024 | 561.70 Mn |
| Sep 30, 2024 | 586.00 Mn |
| Jun 30, 2024 | 600.20 Mn |
| Mar 31, 2024 | 609.70 Mn |
| Dec 31, 2023 | 660.00 Mn |
| Sep 30, 2023 | 457.20 Mn |
| Jun 30, 2023 | 463.60 Mn |
| Mar 31, 2023 | 511.00 Mn |
| Dec 31, 2022 | 564.90 Mn |
| Sep 30, 2022 | 621.50 Mn |
| Jun 30, 2022 | 670.60 Mn |
| Mar 31, 2022 | 723.30 Mn |
| Dec 31, 2021 | 781.70 Mn |
| Sep 30, 2021 | 817.70 Mn |
API Access
Arvinas Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();